|
| |
Articles
1-300 out of 500 article(s) next
| Title |
Author |
Type |
Date |
Words |
| New Oral Anticoagulants Markets. |
|
|
May 22, 2013 |
4988 |
| Deliveries of low molecular weight heparins. |
|
|
May 15, 2013 |
222 |
| The Total Point of Care Diagnositcs Market will Reach $20.9bn in 2015', Says Visiongain Report. |
|
|
May 7, 2013 |
956 |
| Toxicovigilance I: a survey of acute poisonings in South Africa based on Tygerberg Poison Information Centre data. |
Veale, D.J.H.; Wium, C.A.; Muller, G.J. |
Survey |
May 1, 2013 |
4532 |
| CSL Behring Receives FDA Approval of Kcentra(TM) for Urgent Warfarin Reversal in Patients with Acute Major Bleeding. |
|
|
Apr 30, 2013 |
1725 |
| Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement to Evaluate the Efficacy and Safety of PER977 to Reverse the Anticoagulant Activity of the Investigational, Oral, Once-Daily Factor Xa Inhibitor Edoxaban. |
|
|
Apr 25, 2013 |
1491 |
| Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement to Evaluate the Efficacy and Safety of PER977 to Reverse the Anticoagulant Activity of the Investigational, Oral, Once-Daily Factor Xa Inhibitor Edoxaban. |
|
|
Apr 25, 2013 |
1632 |
| Stillbirth or Pre-Term Birth Outcomes Linked to Elevated Risk of Blood Clots After Pregnancy. |
|
|
Apr 2, 2013 |
1056 |
| Photoselective vaporization of the prostate using GreenLight 120-W lithium triborate laser to treat symptomatic benign prostatic hyperplasia: A single-centre prospective study. |
Mosli, Hisham A.; Abdel-Meguid, Taha A.; Abdulwahhab, Mohammad H.; Al-Sayyad, Ahmad; Farsi, Hasan M. |
Clinical report |
Apr 1, 2013 |
3232 |
| Disappearance of a major thrombus in the brachiocephalic vein without anticoagulant therapy in a patient with seminoma: A case report. |
Hongo, Hiroshi; Ide, Hiroki; Hoshino, Katsura; Yasumizu, Yota; Uchida, Yasumitsu; Masuda, Takeshi |
|
Apr 1, 2013 |
1548 |
| Hepatitis E virus and porcine-derived heparin. |
Crossan, C.; Scobie, L.; Godwin, J.; Hunter, J.G.; Hawkes, T.; Dalton, H.R. |
Letter to the editor |
Apr 1, 2013 |
1997 |
| Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism. |
|
|
Mar 27, 2013 |
657 |
| New Oral Anticoagulants Markets. |
|
|
Mar 25, 2013 |
5023 |
| Saint Luke's Neuroscience Institute receives Get With The Guidelines- Stroke Gold Plus Quality Achievement Award. |
|
|
Mar 22, 2013 |
1136 |
| Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs. |
|
|
Mar 8, 2013 |
3237 |
| Germany : New Data on Bayer s Rivaroxaban Underscores Clinical Benefits of Arterial Clot Prevention in Two Major Cardiovascular Disorders. |
|
|
Mar 2, 2013 |
432 |
| Obstructive uropathy secondary to rectus sheath hematoma. |
Dangle, Pankaj P.; Patel, Mitesh B.; Teran, Marcos; Chehval, Micheal J. |
Case study |
Mar 1, 2013 |
1121 |
| Intracranial haemorrhage: increasing use of antiplatelet medication has led to an increase in intracranial haemorrhage as a cause of stroke over the past decade. |
Husein, M. Ben; Feuvre, D. Le |
|
Mar 1, 2013 |
3400 |
| Mehr Law Group Launches New Campaign to Help Victims of Blood Thinner Pradaxa[R]. |
|
|
Feb 21, 2013 |
434 |
| XARELTO to be Studied with Factor Xa Inhibitor Antidote. |
|
|
Feb 5, 2013 |
3059 |
| UPDATE: With Multimedia: U.S. FDA Approves ELIQUIS[R] (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation. |
|
|
Jan 2, 2013 |
3280 |
| Anticoagulation Forum Launches Centers of Excellence Website. |
|
|
Jan 2, 2013 |
557 |
| The optimum number and types of plasma samples necessary for an accurate activated partial thromboplastin time-based heparin therapeutic range. |
Marlar, Richard A.; Gausman, Jana |
|
Jan 1, 2013 |
4113 |
| ELIQUIS[R] (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation. |
|
|
Dec 26, 2012 |
1319 |
| The Launch of Premium-Priced Novel Antithrombotics and an Increased Drug-Treated Population Will Be the Key Growth Drivers of the Atrial Fibrillation Market in Urban China. |
|
|
Dec 19, 2012 |
632 |
| The Atrial Fibrillation Market in Brazil is Expected to Grow at a Rate of 31 Percent Annually over the Next Five Years. |
|
|
Dec 17, 2012 |
680 |
| ELIQUIS[R] (apixaban) Demonstrated Superiority In Reducing A Composite Of Recurrent Venous Thromboembolism And All-Cause Death Without Increasing The Rate Of Major Bleeding Versus Placebo During One Year Of Extended Treatment. |
|
|
Dec 8, 2012 |
1992 |
| Global Anticoagulant Drugs Market & Antithrombotic Drugs Industry Analysis in New Research Reports. |
|
Industry overview |
Nov 20, 2012 |
1790 |
| Global Anticoagulant Drugs Market & Antithrombotic Drugs Industry Analysis in New Research Reports. |
|
Industry overview |
Nov 20, 2012 |
1794 |
| Near-Term Launches of Oral Agents for Venous Thromboembolism (VTE) Treatment/Secondary Prophylaxis Will Trigger a Sharp Decline in the Fortunes of Low-Molecular-Weight Heparins and Vitamin K Antagonists. |
|
|
Nov 20, 2012 |
504 |
| Aspirin cuts recurrent vascular events, VTEs. |
Splete, Heidi |
|
Nov 15, 2012 |
654 |
| Aspirin an option after 3 months of anticoagulants. |
|
Clinical report |
Nov 15, 2012 |
313 |
| Product Liability Lawyers Wright & McGurk Accepting New Pradaxa Blood Thinner Injury Cases. |
|
|
Nov 14, 2012 |
502 |
| The Atrial Fibrillation Drug Market Will Experience Dramatic Growth Over the Next Decade, Increasing from $2.7 Billion in 2011 to $9.2 Billion in 2021. |
|
|
Nov 12, 2012 |
471 |
| Poor Control of Anticoagulant Therapy Leads to Increased Adverse Events for Patients with Atrial Fibrillation (AF). |
|
|
Nov 7, 2012 |
2158 |
| Poor Control of Anticoagulant Therapy Leads to Increased Adverse Events for Patients with Atrial Fibrillation (AF). |
|
|
Nov 7, 2012 |
2198 |
| Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn. |
|
Industry overview |
Nov 6, 2012 |
1248 |
| Law Firm Bond & Taylor Launches New Campaign to Help Victims of Blood Thinner Pradaxa[R]. |
|
|
Nov 4, 2012 |
472 |
| FDA Approves XARELTO (rivaroxaban) to Treat Deep Vein Thrombosis and Pulmonary Embolism, and to Reduce the Risk of Recurrent Events. |
|
|
Nov 2, 2012 |
3252 |
| Portola, Bristol-Myers Squibb and Pfizer Sign Clinical Collaboration Agreement to Study ELIQUIS[R] and Portola's Universal Factor Xa Inhibitor Antidote PRT4445. |
|
|
Nov 1, 2012 |
1698 |
| Sapien valve approval expanded. |
|
Brief article |
Nov 1, 2012 |
170 |
| Effect of dietary sodium nitrate consumption on egg production, egg quality characteristics and some blood indices in native hens of west Azarbaijan province. |
Safary, H.; Daneshyar, M. |
Report |
Nov 1, 2012 |
3669 |
| Irregular heartbeat described as 'modifiable' risk factor for stroke. |
|
|
Oct 29, 2012 |
567 |
| Overview of interventional treatment options for benign prostatic hyperplasia. |
Elhilali, Mostafa M. |
Report |
Oct 1, 2012 |
2625 |
| Generic Plavix competitors set to distribute. |
Richmond, M. |
Brief article |
Oct 1, 2012 |
146 |
| Guidelines bring new strategy in low-risk AF. |
Jancin, Bruce |
|
Sep 15, 2012 |
905 |
| Quercetin 3,7,3',4'-tetrasulphated isolated from Flaveria bidentis inhibits tissue factor expression in human monocyte. |
Guglielmone, H.A.; Nunez-Montoya, S.C.; Agnese, A.M.; Pellizas, C.G.; Cabrera, J.L.; Donadio, A.C. |
Report |
Sep 15, 2012 |
2361 |
| PGXL's Software Makes Drugs More Effective. |
|
|
Sep 5, 2012 |
636 |
| Mildly reduced preoperative ejection fraction increases the risk of stroke in older adults undergoing Coronary Artery Bypass Grafting. |
Reyes, Bernardo; Trotter, Chase; Richards, Mark; Ladd, Jennifer; Broce, Mike; Kali, Maher; Groves, S |
Report |
Sep 1, 2012 |
3206 |
| Stroke prevention agents differ on bleed risk. |
Smith, Jennie |
Clinical report |
Sep 1, 2012 |
758 |
| A misdiagnosis that changed her life forever. |
|
|
Aug 9, 2012 |
820 |
| Kelley Bernheim Dolinsky Warns Pradaxa Patients of Uncontrolled Internal Bleeding Risks. |
|
|
Aug 7, 2012 |
365 |
| FDA Grants Review for XARELTO Supplemental NDAs,. |
|
|
Aug 1, 2012 |
3138 |
| Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration. |
Rose, Adam J.; Petrakis, Beth Ann; Callahan, Patricia; Mambourg, Scott; Patel, Dimple; Hylek, Elaine |
Report |
Aug 1, 2012 |
6859 |
| Nursing interventions and assessments for aneurysmal subarachnoid hemorrhage patients: a mixed methods study involving practicing nurses. |
Wuchner, Staci Sue; Bakas, Tamilyn; Adams, Georgann; Buelow, Janice; Cohn, Jennifer |
Report |
Aug 1, 2012 |
6575 |
| Perioperative anticoagulation. |
Golden, William E.; Hopkins, Robert H. |
|
Aug 1, 2012 |
848 |
| Many at high risk of stroke are given incorrect medicine. |
|
|
Jul 9, 2012 |
806 |
| U.S. FDA Grants Priority Review for XARELTO (rivaroxaban) Supplemental NDAs for the Treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and the Long-Term Prevention of Recurrent DVT and PE. |
|
|
Jul 9, 2012 |
2696 |
| Common belief about pregnancy complications overturned. |
|
Medical condition overview |
Jul 4, 2012 |
813 |
| Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device. |
|
|
Jul 2, 2012 |
1421 |
| First in Michigan: Henry Ford Hospital Procedure Decreases Stroke Risk. |
|
|
Jul 2, 2012 |
504 |
| AutoGenomics and ESBE Scientific Receive Health Canada Clearance for their INFINITI PGx Testing Platform, Warfarin Assay and 2C19 Assay. |
|
|
Jun 27, 2012 |
429 |
| RE-LY Sub-Analysis Suggests Pradaxa (dabigatran etexilate mesylate) Associated with Similar Bleeding Rates and Thromboembolic Complications in Surgery Versus Warfarin. |
|
|
Jun 18, 2012 |
2448 |
| Single line handing ....seven col - Heart doctors fret over new blood thinners. |
|
|
Jun 16, 2012 |
655 |
| Pradaxa (dabigatran etexilate mesylate) U.S. Label Now Affirms Superior Reduction in Ischemic and Hemorrhagic Stroke Versus Warfarin in Patients with Non-Valvular Atrial Fibrillation. |
|
|
Jun 6, 2012 |
1545 |
| Women with irregular heart rhythm at higher risk of stroke than men. |
|
|
Jun 1, 2012 |
447 |
| Lowering the alcohol content of red wine does not alter its cardioprotective properties. |
Lamont, Kim; Blackhurst, Dee; Albertyn, Zulfah; Marais, David; Lecour, Sandrine |
Report |
Jun 1, 2012 |
2141 |
| An evaluation of stroke education in AVAIL registry hospitals. |
West, Angie; Cox, Margueritte; Zimmer, Louise O.; Fedder, Wende; Weber, Cheryl; Drew, Laura; Peterso |
Report |
Jun 1, 2012 |
6418 |
| Estimated rates of treatment failure in first-line antiretroviral treatment in Kinshasa: case of the ACS AMO-Congo. |
Kamangu Ntambwe, Erick; Kawila Mafanda, Euphrasie; Mukumbi, Henri; Mvumbi Lelo, Georges |
Case study |
Jun 1, 2012 |
1909 |
| Value of endothelial dysfunction in the pathogenesis of portal hypertension. |
Gbaruko, U.K.; Slyvka, N.O.; Bojchuk, T.M.; Ivashchuk, O.I.; Plesh, I.A.; Cherevatenko, V.O. |
Report |
Jun 1, 2012 |
3613 |
| Impact of disease-specific orientation on new graduate nurse satisfaction and knowledge retention. |
Ballard, Julie; Mead, Cindy; Richardson, Deborah; Lotz, Abby |
|
May 31, 2012 |
4017 |
| Pill for irregular heartbeat shown green flag. |
|
|
May 23, 2012 |
533 |
| Study of First-in-Class WATCHMAN Device Shows 75 Percent Reduction in Stroke Risk in Patients With Atrial Fibrillation not Eligible for Oral Anticoagulation Therapy. |
|
|
May 14, 2012 |
1345 |
| Study of First-in-Class WATCHMAN Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy. |
|
|
May 11, 2012 |
1624 |
| Preliminary Results of Prospective Trial Suggest Warfarin May Be a Safer Option for Patients than Alternative Therapies. |
|
|
May 4, 2012 |
848 |
| Naturopathic management of infections of the heart and their sequelae. |
Mikolai, Jeremy; Wilner, Martin |
Clinical report |
May 1, 2012 |
8211 |
| The management of extracorporeal carbon dioxide removal device in a diffuse alveolar haemorrhage. |
Lopez-Delgado, J.C.; Sabater-Riera, J.; Avila-Espinoza, R.E. |
Letter to the editor |
May 1, 2012 |
1081 |
| Once-daily oral anticoagulant receives positive Common Drug Review recommendation for stroke prevention in atrial fibrillation. |
|
Clinical report |
Apr 23, 2012 |
1111 |
| United Arab Emirates : GLORIA TM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced. |
|
|
Apr 21, 2012 |
420 |
| United Arab Emirates : Leading medical and patient organisations join forces to improve stroke prevention in atrial fibrillation. |
|
|
Apr 19, 2012 |
458 |
| Frost & Sullivan: Large Atrial Fibrillation Population with Unmet Needs Triggers Growth in the U.S. Anticoagulant Market. |
|
|
Apr 3, 2012 |
913 |
| Frost & Sullivan: Large Atrial Fibrillation Population with Unmet Needs Triggers Growth in the U.S. Anticoagulant Market. |
|
|
Apr 3, 2012 |
906 |
| Despite Gaining FDA Approval within the Past Year, Bayer/Janssen's Xarelto and Astrazeneca's Brilinta Are Already Well Represented on Hospital Formularies, According to a Recent BioTrends Report. |
|
|
Apr 2, 2012 |
615 |
| Stroke guidelines under development. |
Ault, Alicia |
|
Apr 1, 2012 |
706 |
| Largest Warfarin Patient Self-Testing Study Results Establish New Standard of Care. |
|
Clinical report |
Mar 27, 2012 |
838 |
| XARELTO[R] (rivaroxaban) Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study. |
|
|
Mar 26, 2012 |
3090 |
| Sunpeaks Ventures Engages Former All-Star Player and Current Professional Basketball Head Coach as National Clotamin Spokesperson. |
|
|
Mar 17, 2012 |
586 |
| Sunpeaks Ventures Announces Addition of Dakota Drug Inc. as Wholesale Distributor of Clotamin. |
|
|
Mar 9, 2012 |
539 |
| Sunpeaks Ventures Enter Final Stages of Negotiations to Engage Former All-Star NBA Player and Current NBA Head Coach as National Clotamin Spokesperson. |
|
|
Mar 8, 2012 |
615 |
| Sunpeaks Ventures Seeks Profits in $11.2 Billion Global Anticoagulant Market. |
|
|
Mar 7, 2012 |
594 |
| German Left Atrial Appendage Device Market to Challenge Novel Anticoagulants. |
|
|
Mar 7, 2012 |
656 |
| If You Have Risk Factors for, and Symptoms of, Deep Vein Thrombosis, Be Aggressive in Seeking Proper Diagnosis and Treatment; It Could Save Your Life. |
|
|
Mar 5, 2012 |
794 |
| Paediatric anticoagulation guidelines. |
Schapkaitz, E.; Sherman, G.G.; Jacobson, B.F.; Haas, S.; Buller, H.R.; Davies, V.; Diar, H.; Peters, |
Report |
Mar 1, 2012 |
3710 |
| Gastric outlet obstruction secondary to spontaneous intramural haematoma as a complication of warfarin treatment. |
Arain, J.; Al-Dabbagh, A. |
Case study |
Mar 1, 2012 |
1201 |
| U.S. FDA Grants Priority Review for XARELTO[R] (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome. |
|
|
Feb 27, 2012 |
2322 |
| Aspirin, warfarin equal in heart failure. |
Zoler, Mitchel L. |
|
Feb 15, 2012 |
1006 |
| Bleeding more likely from warfarin than rivaroxaban. |
Sullivan, Michele G. |
|
Feb 15, 2012 |
767 |
| Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome p450 enzymes by bilobalide in mice. |
Taki, Yuko; Yokotani, Kaori; Yamada, Shizuo; Shinozuka, Kazumasa; Kubota, Yoko; Watanabe, Yasuo; Ume |
Report |
Feb 15, 2012 |
5497 |
| Instrumentation Laboratory Introduces Fully Automated HemosIL[R] AcuStar HIT Assay Panel in Europe and International Regions. |
|
|
Feb 14, 2012 |
758 |
| New anti-clotting pill better at cutting stroke risk than old treatments. |
|
|
Feb 3, 2012 |
141 |
| New stroke-prevention drugs spur a-fib guides. |
Splete, Heidi |
|
Feb 1, 2012 |
472 |
| Do-it-yourself anticoagulation can be safe and effective. |
|
|
Feb 1, 2012 |
231 |
| Janssen Research Submits Application to FDA. |
|
|
Jan 31, 2012 |
1197 |
| 'Antithrombotic Drug Market Will Rise to 24.4 Billion Dollars in 2015' Says Visiongain. |
|
|
Jan 19, 2012 |
2030 |
| Exciting development helps patients get better, safer care closer to home; Dr Paul Myres explains the latest 1,000 Lives Plus work to diagnose and improve the care of patients with irregular heartbeats. |
|
|
Jan 16, 2012 |
614 |
| Immune response of broiler chickens fed diets supplemented with different level of chromium methionine under heat stress conditions. |
Ebrahimzadeh, S.K.; Farhoomand, P.; Noori, K. |
Report |
Jan 7, 2012 |
3152 |
| Fondaparinux-associated heparin-induced thrombocytopenia. |
Burch, Micah; Cooper, Barry |
Clinical report |
Jan 1, 2012 |
1820 |
| Same-day discharge after percutaneous coronary intervention in light of the society for cardiovascular angiography and intervention's proposed guidelines: a single-center experience. |
Khouri, Yazan; Jain, Sachin Kumar Amruthlal; Serajian, Asif; Shaw, Michael; Zughaib, Marcel |
Clinical report |
Jan 1, 2012 |
2871 |
| Aspirin slashed blood clot recurrence by 40%. |
Brunk, Doug |
|
Jan 1, 2012 |
652 |
| inThought Report Says New Wave of Cardiology Drugs to Be Big Boon. |
|
|
Dec 20, 2011 |
1249 |
| Bayer's Xarelto (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis. |
|
|
Dec 19, 2011 |
1718 |
| ThromboGenics and BioInvent Complete Enrollment of Phase IIb Trial With TB-402 Ahead of Schedule. |
|
|
Dec 16, 2011 |
1392 |
| ThromboGenics and BioInvent Complete Enrolment of Phase IIb Trial with TB-402 ahead of schedule. |
|
|
Dec 16, 2011 |
1282 |
| MAJOR improvements are needed in [...]. |
|
|
Dec 12, 2011 |
156 |
| MAJOR improvements are needed in [...]; HEALTH IN BRIEF... |
|
|
Dec 5, 2011 |
106 |
| Inpatient anticoagulation. |
|
Book review |
Dec 1, 2011 |
141 |
| Pregnancy-induced osteomalasia: case report/Gebeligin tetikledigi osteomalazi: olgu sunumu. |
Ozgen, Merih; Armagan, Onur |
Case study |
Dec 1, 2011 |
1961 |
| Eisai Announce Japan Launch of Oral Anticoagulant Warfarin Granules 0.2%. |
|
|
Nov 30, 2011 |
464 |
| Research and Markets: Inpatient Anticoagulation. The First Practical Guide for Hospitalists on the Use of Anticoagulants in Hospitalized Patients. |
|
|
Nov 22, 2011 |
411 |
| Fitch: New Use of JNJ Blood Thinner Could Thicken Cash. |
|
|
Nov 15, 2011 |
424 |
| Rivaroxaban passes for stroke prevention. |
|
|
Nov 15, 2011 |
178 |
| FDA Approves XARELTO (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation. |
|
|
Nov 4, 2011 |
3122 |
| SMH-Kobernick Anchin Open Specialty Clinic to Help People Safely Manage Blood Thinner Medications. |
|
|
Nov 2, 2011 |
722 |
| Anti-Clotting Drugs Do Not Increase Bleeding Risk in GI Procedure, Mayo Study Finds. |
|
Clinical report |
Nov 1, 2011 |
477 |
| Retropharyngeal haematoma - an unusual cause of airway obstruction. |
Lin, M.J.; Sinclair, C. |
Case study |
Oct 21, 2011 |
834 |
| Canyon Pharmaceuticals Honored with Frost & Sullivan Award for Product Differentiation Excellence in Parenteral Anticoagulants. |
|
|
Oct 18, 2011 |
431 |
| The Atrial Fibrillation Drug Market Will Increase Nearly Eight-Fold over the Next Decade, Growing from $1.3 Billion in 2010 to over $10 Billion in 2020. |
|
|
Oct 18, 2011 |
553 |
| The impact of a statewide stroke quality improvement program: Colorado Stroke Alliance and Colorado Stroke Registry. |
Murphy, Paul; Smith, Don; Vislosky, Michael; Tripputi, Mark; Cumbler, Ethan; Blakie, Julie; Wilde, M |
|
Oct 1, 2011 |
3493 |
| Nutrition hotline. |
Mangels, Reed |
|
Oct 1, 2011 |
969 |
| ?Es necesario heparinizar el suero de cebado del dializador? |
Sanchez Villar, Isidro; Estupinan Torres, Sara; Ledesma Galindo, David; Garcia de La Cruz Maestro, N |
|
Oct 1, 2011 |
3164 |
| Anticoagulacion del circuito extracorporeo esterilizado con oxido de etileno y rayos gamma: ?necesitan las mismas dosis de heparina? |
Munoz Pilar, Sonia; San Juan Miguelsanz, Marta Isabel; Conde Gomez, Elena; Gamarra Gonzalez, Veronic |
|
Oct 1, 2011 |
3547 |
| Hemostasis test compatibility with capped and uncapped tubes. |
Finnegan, Kathleen; Cutsforth, Gwyn |
Report |
Sep 22, 2011 |
2325 |
| Anticlotting drug (Vorapaxar[R]) fails to meet expectations in major trial. |
|
Brief article |
Sep 22, 2011 |
291 |
| Surveyed U.S. Cardiologists Say That Superior Stroke Prevention Efficacy and Less Major Bleeding Than Warfarin Would Propel Apixaban to Capture the Leading Patient Share of New Anticoagulants for Atrial Fibrillation. |
|
|
Sep 14, 2011 |
628 |
| New hope for stroke victims in the North; Drug available from today for AF sufferers. |
|
|
Sep 5, 2011 |
587 |
| New hope for stroke victims. |
|
|
Sep 5, 2011 |
215 |
| First anti-stroke pill in 50 years goes on sale. |
|
|
Sep 5, 2011 |
300 |
| Anticoagulation therapy as a supplement to recanalization for the treatment of sigmoid sinus thrombosis: a case report. |
Rosenberg, Joshua D.; Parikh, Sanjay R. |
Case study |
Sep 1, 2011 |
1421 |
| New anticoagulant pill cuts stroke deaths by 11 pc. |
|
|
Aug 29, 2011 |
274 |
| Research and Markets: Will Next Generation Oral Anticoagulants Replace Warfarin as Mainstay Therapy? |
|
|
Aug 25, 2011 |
467 |
| HOPE OVER HEART PILL. |
|
|
Aug 11, 2011 |
142 |
| Stroke preventative drug launched. |
Khobetsi, Lorato |
|
Aug 5, 2011 |
313 |
| A program to improve secondary stroke prevention: the Colorado Neurological Institute stroke preventing recurrence of thromboembolic events through coordinated treatment program. |
Menard, Michelle M.; Smith, Don B.; Taormina, Cristina |
Clinical report |
Aug 1, 2011 |
3857 |
| Direct thrombin inhibitors: clinical uses, mechanism of action, and laboratory measurement. |
Rhea, Jeanne M. |
|
Aug 1, 2011 |
2854 |
| Enrollment Objective Achieved for Aspirin and Clopidogrel Patient Group of the On-X Heart Valve Anticoagulation Clinical Study. |
|
Clinical report |
Jul 26, 2011 |
895 |
| Multimedia: FDA Approves XARELTO (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery. |
|
|
Jul 1, 2011 |
1939 |
| NY: Drs. fail to give anticoagulant to a-fib pt.: Denial of Drs.' motion for judgment affirmed. |
|
Case overview |
Jul 1, 2011 |
435 |
| Documentation of physiological parameters and blood profile in newly born Kajli lambs. |
Saddiqi, H.A.; Nisa, M.; Mukhtar, N.; Shahzad, M.A.; Jabbar, A.; Sarwar, M. |
Report |
Jul 1, 2011 |
4915 |
| Effects of fermented soybean meal on immune response of weaned calves with experimentally induced lipopolysaccharide challenge. |
Kwon, In Hyuk; Kim, Myung Hoo; Yun, Cheol-Heui; Go, Jong Yeol; Lee, Chan Ho; Lee, Hyun June; Phipek, |
Report |
Jul 1, 2011 |
4644 |
| The relation between physiological parameters and the anxiety state in competitive men handball players during official competitions. |
Acsinte, Alexandru; Alexandru, Eftene; Pacuraru, Alexandru; Ghervan, Petru; Mihaila, Ion |
Report |
Jul 1, 2011 |
3110 |
| Four Clinical Trials Document the On-X Heart Valve's Exceptional Clinical Performance. |
|
Clinical report |
Jun 27, 2011 |
770 |
| Endotis Intiates Phase IIa Study of First-in-Class Neutralizable Anticoagulant in Open-Heart Surgery. |
|
|
Jun 22, 2011 |
439 |
| ELIQUIS[R] (apixaban) Meets Primary and Key Secondary Endpoints in Phase 3 ARISTOTLE Study. |
|
Clinical report |
Jun 22, 2011 |
1217 |
| Anticoagulant medication bivalirudin improves survival in heart attack. |
|
Clinical report |
Jun 14, 2011 |
447 |
| Pharmigene Secures Patents in Europe, Japan, New Zealand, Mexico, Singapore, and Taiwan Related to VKORC1-1639 as a Predictor to Patients' Sensitivity to Warfarin. |
|
|
Jun 2, 2011 |
451 |
| Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. |
Ntusi, Ntobeko B.A.; Badri, Motasim; Gumedze, Freedom; Wonkam, Ambroise; Mayosi, Bongani M. |
Report |
Jun 1, 2011 |
5029 |
| J Zoo Wildl Med.: Anticoagulant rodenticide exposure and toxicosis in four species of birds of prey presented to a wildlife clinic in Massachusetts, 2006-2010. |
Murray, M. |
Brief article |
Jun 1, 2011 |
252 |
| Study on Cammomile (Matricaria chamomilla L.) usage and farming. |
Mohammad, Sharrif moghaddasi |
Report |
Jun 1, 2011 |
5062 |
| Recombinant thromboplastins vs tissue-extract thromboplastins in patients on unstable oral anticoagulant therapy. |
Remijn, Jasper A.; Wildeboer, Bertil; van Suijlen, Jeroen D.E.; Adriaansen, Henk J. |
Letter to the editor |
Jun 1, 2011 |
1102 |
| Warfarin recalled. |
|
|
May 15, 2011 |
123 |
| On-X Life Technologies, Inc. to Host Satellite Symposium at American Association for Thoracic Surgery Meeting. |
|
|
May 5, 2011 |
627 |
| PolyMedix Presents Data on PMX-60056 at the American Heart Association ATVB-2011 Meeting. |
|
|
May 3, 2011 |
1006 |
| Effect of supplementing betaine on performance, carcass traits and immune responses in broiler chicken fed diets containing different concentrations of methionine. |
Rao, S.V. Rama; Raju, M.V.L.N.; Panda, A.K.; Saharia, Poonam; Sunder, G. Shyam |
Report |
May 1, 2011 |
6097 |
| Too thin for comfort: a red-blooded medical challenge: creating a safer treatment to counteract the effect of blood thinners. |
Thaler, Sebastian |
|
May 1, 2011 |
1925 |
| Secondary prevention of stroke. |
Golden, William E.; Hopkins, Robert H. |
|
May 1, 2011 |
871 |
| Why am I always cold? |
|
Brief article |
May 1, 2011 |
109 |
| Effects of clove extract as an anesthetic on sperm motility traits and some hematological parameters in Prussian carp Carassius gibelio. |
Farahi, Amin; Kasiri, Milad; Talebi, Amir; Sudagar, Mohammad |
Report |
May 1, 2011 |
2193 |
| No effect of anticoagulant on [Hb A.sub.1c] analysis by the IFCC reference procedure. |
Biswas, Nilanjana; Raut, Narendra; Mathew, Rahul G.; Sil, Aparna; Manohar, Venkat |
Letter to the editor |
May 1, 2011 |
1033 |
| ThromboGenics and BioInvent Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis. |
|
|
Apr 27, 2011 |
1557 |
| BioInvent and ThromboGenics Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis. |
|
|
Apr 27, 2011 |
1461 |
| Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA(R) (Edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism After Major Orthopedic Surgery. |
|
|
Apr 22, 2011 |
1200 |
| Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery. |
|
|
Apr 22, 2011 |
1072 |
| Research and Markets: Essential Strategic Insight for Key Stakeholders in the Anticoagulants Market. |
|
|
Apr 15, 2011 |
349 |
| Radix/Rhizoma Notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. |
He, Li; Chen, Xiaoyan; Zhou, Muke; Zhang, Dongping; Yang, Jie; Yang, Mi; Zhou, Dong |
Report |
Apr 15, 2011 |
4457 |
| Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis C.H. Wright in vitro and in vivo. |
Gong, Guohua; Qin, Yuan; Huang, Wen |
Report |
Apr 15, 2011 |
5446 |
| Secondary prevention of stroke. |
Golden, William E.; Hopkins, Robert H. |
|
Apr 15, 2011 |
814 |
| MORE than a million people [...]. |
|
|
Apr 11, 2011 |
257 |
| On-X Heart Valve PROACT Trial Preliminary Report Provides Evidence toward Maintaining Patients with Less Warfarin. |
|
|
Apr 6, 2011 |
995 |
| In Study of Acutely Ill Patients Rivaroxaban Compares Favorably With Enoxaparin in Preventing Venous Thromboembolism but With an Increased Rate of Bleeding. |
|
Report |
Apr 5, 2011 |
1613 |
| In Europe, Emerging Novel Factor Xa Inhibitors Are Set to Displace Use of Low-Molecular-Weight Heparins and Unfractionated Heparins in the Management of Ischemic Complications Associated with Acute Coronary Syndrome. |
|
Disease/Disorder overview |
Apr 5, 2011 |
587 |
| Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System. |
|
|
Apr 3, 2011 |
1369 |
| Nephrectomy in patients with Caroli's and ADPKD may be associated with increased morbidity. |
Aguilar, Martin; Meterissian, Sarkis; Levesque, Sebastien; Andonian, Sero |
Case study |
Apr 1, 2011 |
2057 |
| Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans, LA. |
|
Financial report |
Mar 28, 2011 |
833 |
| More Than 50 Percent of Surveyed Orthopedic Surgeons and 70 Percent of Surveyed MCO Pharmacy Directors Chose Sanofi-Aventis's Lovenox as the Most Effective Anticoagulant for VTE Primary Prophylaxis, When Compared to Other Available Therapies. |
|
|
Mar 22, 2011 |
768 |
| Apixaban trumps aspirin in reducing stroke. |
Smith, Jennie |
Clinical report |
Mar 1, 2011 |
625 |
| Study finds racial disparity in AF awareness. |
Jancin, Bruce |
Clinical report |
Mar 1, 2011 |
252 |
| Ambient particulate matter air pollution and venous thromboembolism in the Women's Health Initiative Hormone Therapy trials. |
Shih, Regina A.; Griffin, Beth Ann; Salkowski, Nicholas; Jewell, Adria; Eibner, Christine; Bird, Chl |
Report |
Mar 1, 2011 |
8392 |
| New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin in Reducing Stroke and Systemic Embolism in Patients with Atrial Fibrillation Unsuitable for Warfarin Therapy. |
|
|
Feb 10, 2011 |
2033 |
| PolyMedix Initiates Phase 2 Clinical Trial with Novel Heptagonist, PMX-60056. |
|
|
Feb 9, 2011 |
1136 |
| Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents. |
Alsaikhan, Bader; Andonian, Sero |
Report |
Feb 1, 2011 |
3938 |
| Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours. |
Casey, Georgina |
Report |
Feb 1, 2011 |
4569 |
| Risk behaviour of lead-exposed workers and hearing impairment. |
Galal, Salma; El-Samra, Gamal H.; Mazhar, Manal; El-Kholy, Fatma; Hegazy, Amel |
Report |
Feb 1, 2011 |
3374 |
| Annual Market Potential for LAA Occlusion/Exclusion is $500 Million in the US, According to Millennium Research Group. |
|
|
Jan 19, 2011 |
589 |
| Effect of antioxidants on physio-biochemical and hematological parameters in broiler chicken at high altitude. |
Biswas, A.; Ahmed, M.; Bharti, V.K.; Singh, S.B. |
Report |
Jan 13, 2011 |
2647 |
| New Drug Application Submitted to FDA for Rivaroxaban for Prevention of Stroke in Patients with Atrial Fibrillation. |
|
|
Jan 5, 2011 |
627 |
| New anticlotting drug. |
Zipes, Douglas P. |
Brief article |
Jan 1, 2011 |
114 |
| New option for atrial fibrillation. |
Acklin, Cara |
Brief article |
Jan 1, 2011 |
130 |
| Strict Heart Rate Control Provides No Advantage Over Lenient Approach. |
|
|
Dec 20, 2010 |
1427 |
| The effect of motivational interviewing after ischemic stroke on patient knowledge and patient satisfaction with care: a pilot study. |
Byers, Ann Marie; Lamanna, Lenore; Rosenberg, Antonieta |
Report |
Dec 1, 2010 |
6744 |
| Anticoagulants, antiplatelets, and thrombolytics, 2d ed. |
|
Book review |
Dec 1, 2010 |
109 |
| Evaluation of a pediatric blood filter for whole blood transfusions in domestic chickens (Gallus gallus). |
Jankowski, Gwen; Nevarez, Javier |
Report |
Dec 1, 2010 |
4702 |
| Artifact hyperfibrinolysis in thromboelastography with the use of a heparinase cup. |
Moreland, Virginia; Teruya, Jun; Jariwala, Purvi |
Letter to the editor |
Dec 1, 2010 |
607 |
| Pfizer halts blood thinner study due to bleeding. |
|
|
Nov 30, 2010 |
361 |
| Court says blood thinner was 'unreasonably dangerous'. |
|
|
Nov 30, 2010 |
435 |
| Bayer, J&J Anti-clot drug Excels in stroke trial. |
|
|
Nov 22, 2010 |
487 |
| PolyMedix Announces Three Presentations at Upcoming American Society of Hematology Meeting. |
|
|
Nov 22, 2010 |
958 |
| GAO says FDA risked integrity. |
|
|
Nov 16, 2010 |
668 |
| Anticoagulants curb prostate cancer mortality: aspirin leads the pack, lowering the death risk by nearly 50% in a study of more than 5,000 men. |
Sullivan, Michele G. |
Report |
Nov 15, 2010 |
770 |
| PolyMedix Presents PMX-60056 Clinical Data at the American Heart Association Scientific Sessions Meeting. |
|
Clinical report |
Nov 15, 2010 |
1479 |
| Boehringer Ingelheim GmbH's (Ingelheim DEU) Pradaxa blood thinner lowered the risk of major bleeding in patients taking the drug to prevent another stroke or stroke-like attack, according to a new analysis of a study. |
|
|
Nov 15, 2010 |
649 |
| Bayer AG's (leverkusen DEU) blood thinner Xarelto matched the standard therapy at preventing blood clots in patients with an irregular heartbeat, results that may determine its success in a market worth as much as $14 billion a year. |
|
|
Nov 8, 2010 |
240 |
| Roche Introduces CoaguChek Link Web Resource to Streamline Anticoagulation Management for Doctors and Patients. |
|
Clinical report |
Nov 8, 2010 |
1179 |
| PolyMedix Announces Acceptance of Two Presentations at the American Heart Association Meeting. |
|
|
Nov 4, 2010 |
899 |
| Scientific Protein Labs failed to report complaints about Chinese heparin: FDA. |
|
|
Nov 2, 2010 |
508 |
| B. Braun recalls heparin contaminated with oversulfated chondroitin sulfate. |
|
Brief article |
Nov 2, 2010 |
140 |
| Boehringer Ingelheim's Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3. |
|
|
Nov 1, 2010 |
1587 |
| Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management. |
|
|
Oct 29, 2010 |
490 |
| Aspirin use 'cuts risk of death from prostate cancer by more than half'. |
|
|
Oct 26, 2010 |
293 |
| PolyMedix Provides Updates on PMX-60056 Heptagonist Program. |
|
|
Oct 21, 2010 |
1861 |
| New Study Data Shows Advantages of GORE[R] PROPATEN[R] Vascular Grafts Compared with Standard ePTFE Grafts at One Year. |
|
Clinical report |
Oct 12, 2010 |
699 |
| Coag tests get tweaked. |
Rogoski, Richard R. |
|
Oct 1, 2010 |
1077 |
| Sellado de cateteres con gelafundina versus heparina sodica. |
Sierra Diaz, Ruben |
Clinical report |
Oct 1, 2010 |
1826 |
| European Hospital Anticoagulant Market Dominated by Sanofi-Aventis's Clexane. |
|
|
Sep 28, 2010 |
426 |
| GenMark Diagnostics Selected as Diagnostic Platform in Warfarin Clinical Trial. |
|
Clinical report |
Sep 27, 2010 |
488 |
| Apixaban bests aspirin for stroke reduction in AF. |
Jancin, Bruce |
|
Sep 15, 2010 |
890 |
| pounds 2.5 million injection for blood clot technology; Massive investment put into hand-held monitor. |
|
|
Sep 15, 2010 |
564 |
| Natural anticoagulant levels in children with chronic liver disease/ Kronik karaciger hastaligi olan cocukluklarda dogal antikoagulan duzeyleri. |
Gulcan, E. Mahir; Kutlu, Tufan; Erkan, Tulay; Cokugras, Fugen Cullu |
Report |
Sep 1, 2010 |
2260 |
| DAIICHI SANKYO Announces Enrollment in the Two Largest Single Phase III Trials so far for the Prevention of Stroke in AF and for the Treatment of VTE is Proceeding as Planned. |
|
|
Sep 1, 2010 |
1514 |
| Deprivation of esophageal boluses and dry forage intake in large-type goats. |
Van Thang, Tran; Sunagawa, Katsunori; Nagamine, Itsuki; Kato, Seiyu |
Report |
Sep 1, 2010 |
7924 |
| Being under 45 raises VTE risk in cirrhosis. |
Napoli, Denise |
|
Sep 1, 2010 |
631 |
| Congressmen press Hamburg on Chinese heparin. |
|
|
Aug 10, 2010 |
437 |
| Boca Raton Community Hospital First in Florida to Use New Device for Stroke Prevention in Atrial Fibrillation Patients. |
|
|
Aug 10, 2010 |
867 |
| Raising awareness of heparin-induced thrombocytopenia in subarachnoid hemorrhage. |
Robinson, Jennifer D. |
Clinical report |
Aug 1, 2010 |
2180 |
| Standardized admission and discharge templates to improve documentation of the joint commission on accreditation of healthcare organization performance markers. |
Whited, Karen; Aiyagari, Venkatesh; Calderon-Arnulphi, Mateo; Cursio, John; Pandey, Dilip; Hillmann, |
Report |
Aug 1, 2010 |
2787 |
| Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. |
Lupidi, G.; Scire, A.; Camaioni, E.; Khalife, K.H.; De Sanctis, G.; Tanfani, F.; Damiani, E. |
Report |
Aug 1, 2010 |
6131 |
| United States : AstraZeneca asks FDA to approve its blood thinner. |
|
|
Jul 28, 2010 |
202 |
| United States : Market divided as FDA issues briefing information on AstraZeneca blood thinner. |
|
|
Jul 28, 2010 |
351 |
| United States : FDA Questions Effectivness Of AstraZeneca Anticlotting Drug. |
|
|
Jul 27, 2010 |
278 |
| CMS Approves Clinical Study of Genetic Test to Predict Patient Response to Leading Anticoagulant Drug Warfarin. |
|
|
Jul 26, 2010 |
826 |
| Germany : FDA approves generic blood thinner. |
|
|
Jul 26, 2010 |
420 |
| Eli Lilly pitches blood test to aid sales of blood thinner. Eli Lilly & Co. |
|
|
Jul 19, 2010 |
272 |
| Coumadin recalled for variations in active ingredient. |
|
Brief article |
Jul 13, 2010 |
215 |
| Positive Results from Phase II VTE Prophylaxis Study with TB-402 (Anti-Factor VIII) Presented at the 21st International Congress on Thrombosis in Milan, Italy. |
|
|
Jul 9, 2010 |
1419 |
| EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients. |
|
Clinical report |
Jul 6, 2010 |
816 |
| EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients. |
|
Clinical report |
Jul 6, 2010 |
812 |
| The effect of various concentrations of taurine during in vitro fertilization on the development of bovine embryos fertilized with spermatozoa from three different bulls. |
Tsuzuki, Yasuhiro; Toyama, Hitomi; Nabenishi, Hisashi; Morita, Tetsuo; Ashizawa, Koji |
Report |
Jul 1, 2010 |
5060 |
| Heart defect often causes no symptoms. |
Zipes, Douglas P. |
Brief article |
Jul 1, 2010 |
248 |
| Heparinoides naturais isolados de rodoficeas (Halymenia sp.) arribadas na costa cearense. |
Gurgel Rodrigues, Jose Arievilo; Torres, Valeska Martins; de Alencar, Daniel Barroso; Holanda Sampai |
|
Jul 1, 2010 |
4643 |
| Aplicacion de vibraciones sobre la superficie del dializador. Efecto en la dosis de heparina. |
Sanchez Martin, Alberto; Munoz Garcia, Belen; Sanchez Tocino, Ma. Luz; Villoria Gonzalez, Silvia; He |
Report |
Jul 1, 2010 |
2226 |
| Editorial. |
Joyner, Kelly A., Jr. |
Editorial |
Jun 22, 2010 |
466 |
| Bristol-Myers Squibb Co. |
|
|
Jun 14, 2010 |
226 |
| Community stroke prevention programs: an overview. |
Kozub, Elizabeth |
Report |
Jun 1, 2010 |
5463 |
| CoaguSense Receives FDA Clearance for the CoaguSense Blood Coagulation Testing System for Patient Home Use. |
|
|
Jun 1, 2010 |
725 |
| The role of venous thrombectomy for ilio-femoral vein thrombosis. |
Matley, Philip |
|
Jun 1, 2010 |
1572 |
| Thrombolysis for deep venous thrombosis. |
Marle, J. Van |
Clinical report |
Jun 1, 2010 |
3546 |
| Pulmonary embolism. |
Muckart, David |
|
Jun 1, 2010 |
1688 |
| Vena caval filters: an evidence-based review. |
Paruk, Nishen |
Report |
Jun 1, 2010 |
2608 |
| Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems. |
|
|
May 25, 2010 |
581 |
| Congress faults FDA in heparin case. |
|
|
May 18, 2010 |
372 |
| ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402). |
|
|
May 6, 2010 |
1501 |
| BioInvent and ThromboGenics Announce Positive Topline Results from Phase II VTE Prophylaxis Study with Anti-Factor VIII (TB-402). |
|
|
May 6, 2010 |
1255 |
| ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402). |
|
|
May 6, 2010 |
1508 |
| Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient Safety Goal. |
|
|
May 6, 2010 |
1320 |
| Evaluation of Falcivax against Quantitative Buffy Coat (QBC) for the diagnosis of malaria. |
Gurung, Bimala; Bairy, Indira; Jagadishchandra; Manohar, Chetan |
Clinical report |
May 1, 2010 |
2863 |
| Effect of temperature storage on hematological parameters of Avian turkey blood. |
Hadzimusic, Nejra; Katica, Muhamed; Muharemovic, Zijad; Musanovic, Jasmin |
Clinical report |
May 1, 2010 |
2415 |
| EHSI to Add Blood Disorder Treatment Module to Medical iPhone App. |
|
|
Apr 26, 2010 |
557 |
| EHSI Initiates Selection of Protocols and Equipment for New Medical iPhone App. |
|
|
Apr 21, 2010 |
530 |
| Toddler may have died of heparin overdose. |
|
|
Apr 20, 2010 |
655 |
| Tests confirm that 'new' heparin is less potent. |
|
|
Apr 20, 2010 |
268 |
| Judge says Sanofi, Bristol can seek $442 million from Apotex. |
|
Brief article |
Apr 19, 2010 |
332 |
| Sulfated polysaccharides isolated from Caulerpa racemosa and Caulerpa cupressoides (Chlorophyceaes)--extraction, fractionation and anticoagulant activity/ Polissacarideos sulfatados isolados das cloroficeas Caulerpa racemosa e Caulerpa cupressoides--extracao, fracionamento e atividade anticoagulante. |
Rodrigues, Jose Arievilo Gurgel; Vanderlei, Edfranck de Sousa Oliveira; Quindere, Ana Luiza Gomes; F |
|
Apr 1, 2010 |
4672 |
| Intravenous orexin reduces LH secretion in castrated camelus dromedaries fed a sub-maintenance diet. |
Khazali, H. |
Report |
Apr 1, 2010 |
3716 |
| Cateter-fistula: Una nueva alternativa en la puncion de accesos vasculares: premio izasa accesos vasculares y nuevas tecnologias. |
Martinez Ocana, Olga; Rodriguez Estaire, Jaime; Ruiz Sanz, Beatriz; Martin Navarro, Juan Antonio; Me |
Clinical report |
Apr 1, 2010 |
2994 |
| The Launches and Uptake of Novel Oral Anticoagulants Will Drive the Venous Thromboembolism Drug Market to Nearly Double by 2018. |
|
|
Mar 30, 2010 |
622 |
| AGA Medical Receives Conditional IDE Approval from FDA to Study Use of AMPLATZER[R] Cardiac Plug to Close the Left Atrial Appendage. |
|
|
Mar 24, 2010 |
1004 |
| [gamma]-LA-supplementation to IVC for IVP bovine embryos. |
Gaja, A.; Meng, C.L.; Sato, M.; Nakajima, T.; Kubota, C.; Kojima, T. |
Report |
Mar 23, 2010 |
5886 |
| An experimental blood thinner being developed by Merck & Co (Whitehouse Station NJ) from a new class of drugs appeared to be safe and effective in a mid-stage study that compared three doses against widely used warfarin in patients with atrial fibrillation. |
|
|
Mar 22, 2010 |
322 |
| Anticoagulants plus acid-suppressive agents: an unsafe combination? |
|
|
Mar 22, 2010 |
335 |
| Pathway Genomics Responds to Medco, Mayo Clinic Study Revealing Gene Testing Reduces Hospitalization Rates for Warfarin Patients. |
|
|
Mar 17, 2010 |
497 |
| Hope for stroke victims. |
|
|
Mar 17, 2010 |
175 |
| Effects of polyurethane coated urea supplement on in vitro ruminal fermentation, ammonia release dynamics and lactating performance of Holstein dairy cows fed a steam-flaked corn-based diet. |
Xin, H.S.; Schaefer, D.M.; Liu, Q.P.; Axe, D.E.; Meng, Q.X. |
Report |
Mar 11, 2010 |
7112 |
| Warfarin users more vulnerable to brain bleeding after stroke treatment. |
|
|
Mar 9, 2010 |
409 |
| Pfizer Inc (New York) and Bristol-Myers Squibb Co's (New York) anti-clotting pill apixaban proved better than standard treatment Lovenox in a late-stage knee surgery trial, boosting prospects for the drug after earlier disappointment. |
|
Brief article |
Mar 8, 2010 |
113 |
| ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In The Prevention Of Venous Thromboembolism Following Knee Replacement Surgery. |
|
Clinical report |
Mar 4, 2010 |
1483 |
| Better blood thinner? |
Zipes, Douglas P. |
|
Mar 1, 2010 |
377 |
| First Direct Thrombin Inhibitor for DVT Prevention Now Available From Canyon Pharmaceuticals. |
|
|
Mar 1, 2010 |
1151 |
| Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat. |
Wang, X.; Lee, W.Y.W.; Or, P.M.Y.; Yeung, J.H.K. |
Clinical report |
Mar 1, 2010 |
5784 |
| Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo. |
Wu, Windy W.P.; Yeung, John H.K. |
|
Mar 1, 2010 |
5474 |
| Serum leptin levels in women with immunological recurrent abortion. |
Zarei, Saeed; Soltanghoraee, Haleh; Mohammadzadeh, Afsaneh; Arefi, Soheila; Zarnani, Amir Hassan; Id |
Report |
Mar 1, 2010 |
3478 |
| Lupus anticoagulant, antiphospholipid syndrome and cardiac surgery. |
Cartwright, B.L.; Bean, M.; Cooper, J.O. |
Case study |
Mar 1, 2010 |
3092 |
| Woodcock cleared of conflict-of-interest allegations in heparin case. |
|
|
Feb 9, 2010 |
534 |
| Excelsior Medical's New Catheter Lock Solution Approved by Health Canada. |
|
|
Feb 9, 2010 |
489 |
| Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S. |
|
Clinical report |
Feb 8, 2010 |
1004 |
| Genetic diversity of a Chinese native chicken breed, Bian chicken, based on twenty-nine microsatellite markers. |
Ding, Fu-Xiang; Zhang, Gen-Xi; Wang, Jin-Yu; Li, Yuan; Zhang, Li-Jun; Wei, Yue Wang, Hui-Hua; Zhang, |
Report |
Feb 1, 2010 |
5522 |
| A historical account of stroke and the evolution of nursing care for stroke patients. |
Nilsen, Marci Lee |
Report |
Feb 1, 2010 |
6810 |
| The management of seizures in brain tumor patients. |
Smith, Kristen Catherine |
Report |
Feb 1, 2010 |
8532 |
| Aspirin fails to prevent recurrent miscarriages. |
Macneil, Jane Salodof |
|
Feb 1, 2010 |
1303 |
| Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo-a single-center study/Kosovo'da kardiyoloji servisine basvuran hastalarda atriyal fibrilasyonun komorbiditeleri ve takibi-Tek merkezli calisma. |
Elezi, Shpend; Qerkini, Gazmend; Bujupi, Liridon; Shabani, Driton; Bajraktari, Gani |
|
Feb 1, 2010 |
4564 |
| Oral anticoagulation in atrial fibrillation: are the problems solved?/Atriyal fibrilasyonda oral antikoagulan tedavi: Sorunlar cozuldu mu? |
Dogan, Umuttan |
|
Feb 1, 2010 |
1020 |
| Amphastar files new appeal in FDA conflict-of-interest case. |
|
|
Jan 26, 2010 |
531 |
|
